Samson Clinical

Samson Clinical Media releases

Stay informed with the latest scientific breakthroughs, clinical milestones, and corporate announcements from Samson Clinical. You can access our latest media releases below, detailing our progress in advancing sublingual minoxidil (SLM) through critical clinical trial phases.

Samson Clinical Announces Last Patient Last Visit in Pivotal Phase III Study of Sublingual Minoxidil for Male Baldness 19-May-26

Samson Clinical Media Releases

1 day ago1 min read

Samson Clinical concludes enrolment for Phase III AGA trial. 17 Nov-25.

Samson Clinical Media Releases

Nov 17, 20252 min read

First Patient Randomised in Samson Clinical Phase III Sublingual Minoxidil Trial for MalePattern Hair Loss (Androgenetic Alopecia)

Samson Clinical Media Releases

Aug 6, 20252 min read

HAIR LOSS IN THE NEWS

Ellen Williamson

Executive Manager Operations & Legal Counsel
Mobile 0421 151 190
ellen.williamson@sinclairdermatology.com.au

SAMSON TEAM

Samson Clinical media contacts

We are available to assist journalists, industry analysts, and publishers with timely data, executive perspectives, and high-resolution media assets regarding Samson Clinical’s drug delivery innovations and ongoing clinical trials.